Skip to main content
SpringerLink
Log in
Book cover

Principles and Practice of Transplant Infectious Diseases pp 775–792Cite as

Parasitic Infections in Transplant Recipients: Toxoplasmosis, Strongyloidiasis, and Other Parasites

  • Chapter
  • First Online:

Abstract

Toxoplasma gondii and Strongyloides stercoralis are important parasitic infections in transplant recipients. These helminths can lead to severe and often life-threatening disease in immunocompromised patients. Toxoplasma gondii can cause an undifferentiated febrile syndrome, encephalitis, pneumonitis, myocarditis, hepatitis, and retinochoroiditis, whereas S. stercoralis infestation, can lead to the hyperinfection syndrome, which carries a high mortality rate. Effective therapies are available for both, but high case-fatality rates result if these syndromes go unrecognized and are not treated promptly. Preventative measures for infected (and often asymptomatic) transplant recipients/candidates are highly effective in preventing overt disease for both parasites, including prophylactic anti-Toxoplasma therapy or ivermectin treatment for patients with occult strongyloidiasis in properly selected patients. Identifying transplant patients at risk for these syndromes is therefore critical, so that these measures can be instituted before life-threatening disease develops. Other important parasitic infections in transplant recipients include Trypanosoma cruzi (the agent of Chagas disease), visceral leishmaniasis, and the free-living amoebae Acanthamoeba and Balamuthia.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;36:1965–76.

    Article  CAS  Google Scholar 

  2. Demar M, Ajzenberg D, Maubon D, et al. Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects. Clin Infect Dis. 2007;45:e88–95.

    Article  PubMed  Google Scholar 

  3. Elbez-Rubinstein A, Ajzenberg D, Darde ML, et al. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis. 2009;199:280–5.

    Article  PubMed  Google Scholar 

  4. Gilbert RE, Freeman K, Lago EG, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2:e277.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Bowie WR, King AS, Werker DH, et al. Outbreak of toxoplasmosis associated with municipal drinking water. Lancet. 1997;350:173–7.

    Article  CAS  PubMed  Google Scholar 

  6. Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009;49:878–84.

    Article  PubMed  Google Scholar 

  7. Cook AJ, Gilbert RE, Buffolano W, et al. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. On behalf of the European research network on congenital toxoplasmosis. BMJ. 2000;321:142–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Montoya JG, Giraldo LF, Efron B, et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis. 2001;33:629–40.

    Article  CAS  PubMed  Google Scholar 

  9. Martino R, Maertens J, Bretagne S, et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis. 2000;31:1188–95.

    Article  CAS  PubMed  Google Scholar 

  10. Rosso F, Les JT, Agudelo A, et al. Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America. Am J Trop Med Hyg. 2008;78:504–8.

    Article  PubMed  Google Scholar 

  11. Luft BJ, Naot Y, Araujo FG, Stinson EB, Remington JS. Primary and reactivated Toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. Ann Intern Med. 1983;99:27–31.

    Article  CAS  PubMed  Google Scholar 

  12. Martino R, Bretage S, Rovira M, et al. Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2000;25:1111–4.

    Article  CAS  PubMed  Google Scholar 

  13. Martino R, Bretagne S, Einsele H, et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis. 2005;40:67–78.

    Article  PubMed  Google Scholar 

  14. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002;185(Suppl 1):S73–82.

    Article  PubMed  Google Scholar 

  15. Public. Health Service, Dept. of Health and Human Services (US) and Food and Drug Administration (FDA). FDA Public Health Advisory: limitations of Toxoplasma IgM commerical test kits. Rockville: Department of Health and Human Services, Food and Drug Administration, 1997 July 25, 1997.

    Google Scholar 

  16. Dorfman RF, Remington JS. Value of lymph-node biopsy in the diagnosis of acute acquired toxoplasmosis. N Engl J Med. 1973;289:878–81.

    Article  CAS  PubMed  Google Scholar 

  17. Wreghitt TG, Hakim M, Gray JJ, et al. Toxoplasmosis in heart and heart lung transplant recipients. J Clin Pathol. 1989;42:194–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367:1521–32.

    Article  PubMed  Google Scholar 

  19. Lam CS, Tong MK, Chan KM, Siu YP. Disseminated strongyloidiasis: a retrospective study of clinical course and outcome. Eur J Clin Microbiol Infect Dis. 2006;25:14–8.

    Article  CAS  PubMed  Google Scholar 

  20. Marcosa LA, Terashimab A, DuPont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg. 2008;102:314–8.

    Article  Google Scholar 

  21. Maguire JH. Intestinal nematodes (roundworms). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practices of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2010. p. 3577–86.

    Google Scholar 

  22. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis. 2001;33:1040–7.

    Article  CAS  PubMed  Google Scholar 

  23. Siddiqui AA, Genta RM, Maguilnik I, Berk SL. Strongyloidiasis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases, 3rd edition – principles, pathogens, & practice. Philadelphia: Elsevier Mosby Saunders; 2011. p. 805–12.

    Chapter  Google Scholar 

  24. Schad GA. Morphology and life history of Strongyloides stercoralis. In: Grove DI, editor. Strongyloidiasis: a major roundworm infection of man. London: Taylor & Francis; 1989. p. 85–104.

    Google Scholar 

  25. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis. 1989;11:755–67.

    Article  CAS  PubMed  Google Scholar 

  26. Yori PP, Kosek M, Gilman RH, et al. Seroepidemiology of strongyloidiasis in the Peruvian Amazon. Am J Trop Med Hyg. 2006;74:97–102.

    Article  PubMed  Google Scholar 

  27. Posey DL, Blackburn BG, Weinberg M, et al. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. Clin Infect Dis. 2007;45:1310–5.

    Article  PubMed  Google Scholar 

  28. Seybolt LM, Christiansen D, Barnett ED. Diagnostic evaluation of newly arrived asymptomatic refugees with eosinophilia. Clin Infect Dis. 2006;42:363–7.

    Article  PubMed  Google Scholar 

  29. Neva FA. Biology and immunology of human strongyloidiasis. J Infect Dis. 1986;153:397–406.

    Article  CAS  PubMed  Google Scholar 

  30. Grove DI. Human strongyloidiasis. Adv Parasitol. 1996;38:251–309.

    Article  CAS  PubMed  Google Scholar 

  31. Genta RM. Dysregulation of strongyloidiasis: a new hypothesis. Clin Microbiol Rev. 1992;5:345–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Schaeffer MW, Buell JF, Gupta M, Conway GD, Akhter SA, Wagoner LE. Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J Heart Lung Transplant. 2004;23:905–11.

    Article  PubMed  Google Scholar 

  33. Seet RC, Lau LG, Tambyah PA. Strongyloides hyperinfection and hypogammaglobulinemia. Clin Diagn Lab Immunol. 2005;12:680–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Morgan JS, Schaffner W, Stone WJ. Opportunistic strongyloidiasis in renal transplant recipients. Transplantation. 1986;42:518–24.

    Article  CAS  PubMed  Google Scholar 

  35. Schad GA. Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. J Infect Dis. 1986;153:178.

    Article  CAS  PubMed  Google Scholar 

  36. Nolan TJ, Schad GA. Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. Transplantation. 1996;62:1038.

    Article  CAS  PubMed  Google Scholar 

  37. Carvalho EM, Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol. 2004;26:487–97.

    Article  CAS  PubMed  Google Scholar 

  38. Gotuzzo E, Terashima A, Alvarez H, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg. 1999;60:146–9.

    Article  CAS  PubMed  Google Scholar 

  39. Hirata T, Uchima N, Kishimoto K, et al. Impairment of host immune response against Strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Am J Trop Med Hyg. 2006;74:246–9.

    Article  PubMed  Google Scholar 

  40. Plumelle Y, Gonin C, Edouard A, et al. Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. Am J Clin Pathol. 1997;107:81–7.

    Article  CAS  PubMed  Google Scholar 

  41. Viney ME, Brown M, Omoding NE, et al. Why does HIV infection not lead to disseminated strongyloidiasis? J Infect Dis. 2004;190:2175–80.

    Article  PubMed  Google Scholar 

  42. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR. 1997;36(Suppl):1–15.

    Google Scholar 

  43. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev. 2004;17:208–17.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Newberry AM, Williams DN, Stauffer WM, Boulware DR, Hendel-Paterson BR, Walker PF. Strongyloides hyperinfection presenting as acute respiratory failure and gram- negative Sepsis. Chest. 2005;128:3681–4.

    Article  PubMed  Google Scholar 

  45. Siddiqui AA, Stanley CS, Skelly PJ, et al. A cDNA encoding a nuclear hormone receptor of the steroid/thyroid hormone-receptor superfamily from the human parasitic nematode Strongyloides stercoralis. Parasitol Res. 2000;86:24–9.

    Article  CAS  PubMed  Google Scholar 

  46. Nolan TJ, Megyeri Z, Bhopale VM, et al. Strongyloides stercoralis: the first rodent model for uncomplicated and hyperinfective strongyloidiasis, the Mongolian gerbil (Meriones unguiculatus). J Infect Dis. 1993;168:1479–84.

    Article  CAS  PubMed  Google Scholar 

  47. Mansfield LS, Niamatali S, Bhopale V, et al. Strongyloides stercoralis: maintenance of exceedingly chronic infections. Am J Trop Med Hyg. 1996;55:617–24.

    Article  CAS  PubMed  Google Scholar 

  48. Fardet L, Généreau T, Poirot JL, Guidet B, Kettaneh A, Cabane J. Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect. 2007;54:18–27.

    Article  PubMed  Google Scholar 

  49. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother. 2007;41:1992–2001.

    Article  CAS  PubMed  Google Scholar 

  50. Liu LX, Weller PF. Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin N Am. 1993;7:655–82.

    CAS  Google Scholar 

  51. Berk SL, Verghese A, Alvarez S, Hall K, Smith B. Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med. 1987;147:1257–61.

    Article  CAS  PubMed  Google Scholar 

  52. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002;66:749–52.

    Article  PubMed  Google Scholar 

  53. Hirata T, Kishimoto K, Kinjo N, Hokama A, Kinjo F, Fujita J. Association between Strongyloides stercoralis infection and biliary tract cancer. Parasitol Res. 2007;101:1345–8.

    Article  PubMed  Google Scholar 

  54. Reddy TS, Myers JW. Syndrome of inappropriate secretion of antidiuretic hormone and nonpalpable purpura in a woman with Strongyloides stercoralis hyperinfection. Am J Med Sci. 2003;325:288–91.

    Article  PubMed  Google Scholar 

  55. Hayashi E, Ohta N, Yamamoto H. Syndrome of inappropriate secretion of antidiuretic hormone associated with strongyloidiasis. Southeast Asian J Trop Med Public Health. 2007;38:239–46.

    PubMed  Google Scholar 

  56. Nielsen PB, Mojon M. Improved diagnosis of Strongyloides stercoralis by seven consecutive stool specimens. Zentralbl Mikrobiol. 1987;263:616–8.

    CAS  Google Scholar 

  57. Agrawal V, Agarwal T, Ghoshal UC. Intestinal strongyloidiasis: a diagnosis frequently missed in the tropics. Trans R Soc Trop Med Hyg. 2009;103:242–6.

    Article  PubMed  Google Scholar 

  58. Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg. 1995;53:248–50.

    Article  CAS  PubMed  Google Scholar 

  59. Hirata T, Nakamura H, Kinjo N, et al. Increased detection rate of Strongyloides stercoralis by repeated stool examinations using the agar plate culture method. Am J Trop Med Hyg. 2007;77:683–4.

    Article  PubMed  Google Scholar 

  60. de Kaminsky RG. Evaluation of three methods for laboratory diagnosis of Strongyloides stercoralis infection. J Parasitol. 1993;79:277–80.

    Article  PubMed  Google Scholar 

  61. Verweij JJ, Canales M, Polman K, et al. Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR. Trans R Soc Trop Med Hyg. 2009;103:342–6.

    Article  CAS  PubMed  Google Scholar 

  62. Basuni M, Muhi J, Othman N, et al. A pentaplex real-time polymerase chain reaction assay for detection of four species of soil-transmitted helminths. Am J Trop Med Hyg. 2011;84:338–43.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Karunajeewa H, Kelly H, Leslie D, Leydon J, Saykao P, Biggs BA. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis. J Travel Med. 2006;13:84–91.

    Article  PubMed  Google Scholar 

  64. Page WA, Dempsey K, McCarthy JS. Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy. Trans R Soc Trop Med Hyg. 2006;100:1056–62.

    Article  CAS  PubMed  Google Scholar 

  65. Safdar A, Malathum K, Rodriguez SJ, Husni R, Rolston KV. Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer. 2004;100:1531–6.

    Article  PubMed  Google Scholar 

  66. Roxby AC, Gottlieb GS, Limaye AP. Strongyloidiasis in transplant patients. Clin Infect Dis. 2009;49:1411–23.

    Article  PubMed  Google Scholar 

  67. Issa H, Aljama MA, Al-Salem AH. Strongyloides stercoralis hyperinfection in a post-renal transplant patient. Clin Exp Gastroenterol. 2011;4:269–71.

    PubMed  PubMed Central  Google Scholar 

  68. Mokaddas EM, Shati S, Abdulla A, et al. Fatal strongyloidiasis in three kidney recipients in Kuwait. Med Princ Pract. 2009;18:414–7.

    Article  PubMed  Google Scholar 

  69. Vilela EG, Clemente WT, Mira RR, et al. Strongyloides stercoralis hyperinfection syndrome after liver transplantation: case report and literature review. Transpl Infect Dis. 2009;11:132–6.

    Article  CAS  PubMed  Google Scholar 

  70. Patel G, Arvelakis A, Sauter BV, Gondolesi GE, Caplivski D, Huprikar S. Strongyloides hyperinfection syndrome after intestinal transplantation. Transpl Infect Dis. 2008;10:137–41.

    Article  CAS  PubMed  Google Scholar 

  71. Mizuno S, Iida T, Zendejas I, Martin TD, Schain DC, Turner B, Fujita S. Strongyloides hyperinfection syndrome following simultaneous heart and kidney transplantation. Transpl Int. 2009;22:251–3.

    Article  PubMed  Google Scholar 

  72. Wirk B, Wingard JR. Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation. Transpl Infect Dis. 2009;11:143–8.

    Article  CAS  PubMed  Google Scholar 

  73. Qazilbash MH, Ueno NT, Hosing C, et al. Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation. Bone Marrow Transplant. 2006;38:393–4.

    Article  CAS  PubMed  Google Scholar 

  74. Orlent H, Crawley C, Cwynarski K, Dina R, Apperley J. Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2003;32:115–7.

    Article  CAS  PubMed  Google Scholar 

  75. Treatment guidelines from the medical letter. Drugs for parasitic infections. Med Lett Drugs Ther. 2007;5(Suppl):e1–e15.

    Google Scholar 

  76. Igual-Adell R, Oltra-Alcaraz C, Soler-Company E, Sánchez-Sánchez P, Matogo-Oyana J, Rodríguez-Calabuig D. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. Expert Opin Pharmacother. 2004;5:2615–9.

    Article  CAS  PubMed  Google Scholar 

  77. Salazar SA, Berk SH, Howe D, Berk SL. Ivermectin vs thiabendazole in the treatment of strongyloidiasis. Inf Med. 1994;11:50–9.

    Google Scholar 

  78. Suputtamongkol Y, Kungpanichkul N, Silpasakorn S, Beeching NJ. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis. Int J Antimicrob Agents. 2008;31:46–9.

    Article  CAS  PubMed  Google Scholar 

  79. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg. 1994;88:344–5.

    Article  CAS  PubMed  Google Scholar 

  80. Marti H, Haji HJ, Savioli L, et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg. 1996;55:477–81.

    Article  CAS  PubMed  Google Scholar 

  81. Pacanowski J, Santos MD, Roux A, et al. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am J Trop Med Hyg. 2005;73:122–4.

    Article  PubMed  Google Scholar 

  82. Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J. Parenteral ivermectin in Strongyloides hyperinfection. Lancet. 2000;355:43–4.

    Article  CAS  PubMed  Google Scholar 

  83. Turner SA, Maclean JD, Fleckenstein L, Greenaway C. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Am J Trop Med Hyg. 2005;73:911–4.

    Article  PubMed  Google Scholar 

  84. Marty FM, Lowry CM, Rodriguez M, et al. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis. 2005;41:e5–8.

    Article  PubMed  Google Scholar 

  85. Pornsuriyasak P, Niticharoenpong K, Sakapibunnan A. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. Southeast Asian J Trop Med Public Health. 2004;35:531–4.

    PubMed  Google Scholar 

  86. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR. 2000;49(RR-10):26–7.

    Google Scholar 

  87. Blackburn B. Strongyloidiasis. In: Pickering LK, Baker CJ, Long SS, JA MM, editors. (American Academy of Pediatrics). Red book: 2006 report of the committee on infectious diseases. 27th ed. Elk Grove Village: American Academy of Pediatrics; 2006. p. 629–31.

    Google Scholar 

  88. Barrett MP, Burchmore RJS, August Stich A, et al. The trypanosomiases. Lancet. 2003;362:1469–80.

    Article  PubMed  Google Scholar 

  89. Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas’ disease in the United States. Clin Microbiol Rev. 2011;24:655–81.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Centers for Disease Control and Prevention, DPDx – Laboratory Identification of Parasites of Public Health Concern, https://www.cdc.gov/dpdx/trypanosomiasisamerican/index.html.

  91. McCormack L, Quiñónez E, Goldaracena N, et al. Liver transplantation using Chagas-infected donors in uninfected recipients: a single-center experience without prophylactic therapy. Am J Transplant. 2012;12:2832–7.

    Article  CAS  PubMed  Google Scholar 

  92. Bern C. Chagas disease in the immunosuppressed host. Curr Opin Infect Dis. 2012;25:450–7.

    Article  CAS  PubMed  Google Scholar 

  93. Chin-Hong PV, Schwartz BS, Bern C, et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the chagas in transplant working group. Am J Transplant. 2011;11:672–80.

    Article  CAS  PubMed  Google Scholar 

  94. Fontes Rezende RE, Lescano MA, Zambelli Ramalho LN, et al. Reactivation of Chagas’ disease in a patient with non-Hodgkin’s lymphoma: gastric, oesophageal and laryngeal involvement. Trans R Soc Trop Med Hyg. 2006;100:74–8.

    Article  PubMed  Google Scholar 

  95. Lury KM, Castillo M. Chagas’ disease involving the brain and spinal cord: MRI findings. Am J Roentgenol. 2005;185:550–2.

    Article  Google Scholar 

  96. Altclas J, Sinagra A, Dictar M, et al. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant. 2005;36:123–9.

    Article  CAS  PubMed  Google Scholar 

  97. Dictar M, Sinagra A, Verón MT, et al. Recipients and donors of bone marrow transplants suffering from Chagas' disease: management and preemptive therapy of parasitemia. Bone Marrow Transplant. 1998;21:391–3.

    Article  CAS  PubMed  Google Scholar 

  98. World Health Organization. World Malaria Report 2012 Geneva, Switzerland. 2012;pp. 53–62.

    Google Scholar 

  99. Walker M, Kublin JG, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis. 2006;42:115–25.

    Article  PubMed  Google Scholar 

  100. Martín-Dávila P, Fortún J, López-Vélez R, et al. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev. 2008;21:60–96.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Mejia R, Booth GS, Fedorko DP, et al. Peripheral blood stem cell transplant-related Plasmodium falciparum infection in a patient with sickle cell disease. Transfusion. 2012;52:2677–82.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Salutari P, Sica S, Chiusolo P, et al. Plasmodium vivax malaria after autologous bone marrow transplantation: an unusual complication. Bone Marrow Transplant. 1996;18:805–6.

    CAS  PubMed  Google Scholar 

  103. O’Donnell J, Goldman JM, Wagner K, et al. Donor-derived Plasmodium vivax infection following volunteer unrelated bone marrow transplantation. Bone Marrow Transplant. 1998;21:313–4.

    Article  PubMed  Google Scholar 

  104. Sah SP, Rijal S, Bhadani PP, Rani S, Koirala S. Visceral leishmaniasis in two cases of leukemia. Southeast Asian J Trop Med Public Health. 2002;33:25–7.

    PubMed  Google Scholar 

  105. Fakhar M, Asgari Q, Motazedian MH, Monabati A. Mediterranean visceral leishmaniasis associated with acute lymphoblastic leukemia (ALL). Parasitol Res. 2008;103:473–5.

    Article  PubMed  Google Scholar 

  106. Sirvent-von Bueltzingsloewen A, Marty P, Rosenthal E. Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell transplanted patients. Bone Marrow Transplant. 2004;33:667–8.

    Article  CAS  PubMed  Google Scholar 

  107. Muñoz P, Valerio M, Eworo A, Bouza E. Parasitic infections in solid-organ transplant recipients. Curr Opin Organ Transplant. 2011;16:565–75.

    Article  PubMed  CAS  Google Scholar 

  108. Machado CM, Levi JE. Transplant-associated and blood transfusion-associated tropical and parasitic infections. Infect Dis Clin N Am. 2012;26:225–41.

    Article  Google Scholar 

  109. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M. Leishmaniasis among organ transplant recipients. Lancet Infect Dis. 2008;8:191–9.

    Article  PubMed  Google Scholar 

  110. Bautista G, Ramos A, Gil S. Visceral leishmaniasis in hematopoietic stem cell transplantation. Transpl Int. 2012;25:e83–5.

    Article  PubMed  Google Scholar 

  111. Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol. 2007;50:1–26.

    Article  CAS  PubMed  Google Scholar 

  112. Kaul DR, Lowe L, Visvesvara GS, Farmen S, Khaled YA, Yanik GA. Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole. Transpl Infect Dis. 2008;10:437–41.

    Article  CAS  PubMed  Google Scholar 

  113. Barete S, Combes A, de Jonckheere JF. Fatal disseminated Acanthamoeba lenticulata infection in a heart transplant patient. Emerg Infect Dis. 2007;13:736–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Walia R, Montoya JG, Visvesvera GS, Booton GC, Doyle RL. A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient. Transpl Infect Dis. 2007;9:51–4.

    Article  CAS  PubMed  Google Scholar 

  115. Fung KT, Dhillon AP, McLaughlin JE, et al. Cure of Acanthamoeba cerebral abscess in a liver transplant patient. Liver Transpl. 2008;14:308–12.

    Article  PubMed  Google Scholar 

  116. Steinberg JP, Galindo RL, Kraus ES, Ghanem KG. Disseminated acanthamebiasis in a renal transplant recipient with osteomyelitis and cutaneous lesions: case report and literature review. Clin Infect Dis. 2002;35:e43–9.

    Article  PubMed  Google Scholar 

  117. Akpek G, Uslu A, Huebner T, et al. Granulomatous amebic encephalitis: an under-recognized cause of infectious mortality after hematopoietic stem cell transplantation. Transpl Infect Dis. 2011;13:366–73.

    Article  CAS  PubMed  Google Scholar 

  118. Centers for Disease Control and Prevention (CDC). Notes from the field: transplant-transmitted Balamuthia mandrillaris – Arizona, 2010. MMWR Morb Mortal Wkly Rep. 2010;59:1182.

    Google Scholar 

  119. Centers for Disease Control and Prevention. (CDC). Balamuthia mandrillaris transmitted through organ transplantation – Mississippi, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:1165–70.

    Google Scholar 

  120. Visvesvara GS. Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment. Curr Opin Infect Dis. 2010;23:590–4.

    Article  CAS  PubMed  Google Scholar 

  121. Bedwani R, Renganathan E, El Kwhsky F. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer. 1998;77:1186–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Hoare M, Gelson WT, Davies SE, Curran M, Alexander GJ. Hepatic and intestinal schistosomiasis after orthotopic liver transplant. Liver Transpl. 2005;11:1603–7.

    Article  PubMed  Google Scholar 

  123. Ahmed K, Safdar K, Kemmer N, Atiq M, Wang J, Neff GW. Intestinal schistosomiasis following orthotopic liver transplantation: a case report. Transplant Proc. 2007;39:3502–4.

    Article  CAS  PubMed  Google Scholar 

  124. Vincenzi R, Neto JS, Fonseca EA, et al. Schistosoma mansoni infection in the liver graft: the impact on donor and recipient outcomes after transplantation. Liver Transpl. 2011;17:1299–303.

    Article  PubMed  Google Scholar 

  125. Muñoz P, Valerio M, Puga D, Bouza E. Parasitic infections in solid organ transplant recipients. Infect Dis Clin N Am. 2010;24:461–95.

    Article  Google Scholar 

  126. Teachey DT, Russo P, Orenstein JM, Didier ES, Bowers C, Bunin N. Pulmonary infection with microsporidia after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004;33:299–302.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stanford University Medical Center, Stanford, CA, USA

    Brian G. Blackburn & José G. Montoya

  2. Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA

    Brian G. Blackburn & José G. Montoya

  3. Palo Alto Medical Foundation Toxoplasma Serology Laboratory, National Reference Center for the Study and Diagnosis of Toxoplasmosis, Palo Alto, CA, USA

    José G. Montoya

Authors
  1. Brian G. Blackburn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. José G. Montoya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian G. Blackburn .

Editor information

Editors and Affiliations

  1. Clinical Associate Professor of Medicine, Texas Tech University Health Sciences Center El Paso, Paul L. Foster School of Medicine, El Paso, TX, USA

    Amar Safdar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Blackburn, B.G., Montoya, J.G. (2019). Parasitic Infections in Transplant Recipients: Toxoplasmosis, Strongyloidiasis, and Other Parasites. In: Safdar, A. (eds) Principles and Practice of Transplant Infectious Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-9034-4_46

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9034-4_46

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-9032-0

  • Online ISBN: 978-1-4939-9034-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation